Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guiding Principles for Physician-Modified Endografts.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2026
Same author

In-Stent Stenosis or Occlusion After Carotid Artery Stenting in Patients Treated With Anticoagulants vs Antiplatelet Therapy.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2026
Same author

Pelvic venous disease and lymphatic dysfunction: evaluating the evidence for a proposed continuum.

The Journal of cardiovascular surgery·2026
Same author

A critical analysis of the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) and the European Carotid Surgery Trial (ECST)-2.

Seminars in vascular surgery·2026
Same author

An international, multispecialty consensus document on the optimal management of patients with internal carotid artery occlusion.

Journal of vascular surgery·2026
Same author

Factors Influencing Sex Specific Outcomes after Complex Endovascular Aortic Aneurysm Repair: Insights from a National Vascular Registry.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2026

Related Experiment Video

Updated: Jun 6, 2026

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
09:36

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

Carotid endarterectomy: current consensus and controversies.

Robbert Meerwaldt1, Linda Hermus, Michel M P J Reijnen

  • 1Department of Surgery, Medical Spectrum Twente, Enschede, The Netherlands.

Surgical Technology International
|November 18, 2010
PubMed
Summary

Carotid artery stenosis increases stroke risk. While carotid endarterectomy (CEA) is standard, carotid angioplasty and stenting (CAS) is evolving. Early intervention benefits symptomatic patients with high-grade stenosis.

Related Experiment Videos

Last Updated: Jun 6, 2026

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
09:36

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

Area of Science:

  • Neurology
  • Vascular Surgery
  • Cardiology

Background:

  • Stroke is a leading cause of death, with carotid artery stenosis contributing significantly to ischemic strokes.
  • Carotid endarterectomy (CEA) is a primary treatment, but carotid angioplasty and stenting (CAS) is emerging as an alternative.
  • Medical management for carotid stenosis has advanced, impacting treatment decisions.

Purpose of the Study:

  • To review the history and current controversies surrounding carotid endarterectomy (CEA).
  • To discuss the evolving role of carotid angioplasty and stenting (CAS) in treating carotid stenosis.
  • To analyze recent meta-analyses on medical treatment, CEA, and CAS.

Main Methods:

  • Review of historical data and recent meta-analyses on carotid interventions.
  • Analysis of current consensus and controversies in carotid endarterectomy (CEA) techniques.
  • Discussion of evolving carotid angioplasty and stenting (CAS) technologies.

Main Results:

  • Carotid endarterectomy (CEA) remains the gold standard, particularly for high-grade stenosis.
  • Optimal timing for carotid interventions in symptomatic patients is crucial for stroke risk reduction.
  • Patching is preferred over primary closure in CEA; shunting, CEA techniques, and anesthesia type show no significant outcome differences.

Conclusions:

  • Carotid endarterectomy (CEA) is the current gold standard for high-grade stenosis, especially in symptomatic patients.
  • The role of carotid interventions for asymptomatic patients remains debated due to improved medical treatments.
  • Future developments in CAS and plaque analysis may offer new treatment options for specific patient subgroups.